CLO21-014: Impact of Late Dosing on Testosterone Suppression With Two Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere – an Analysis of US Clinical Data

View More View Less
  • 1 Florida Cancer Specialists & Research Institute, Gainesville, FL
  • | 2 Tolmar Pharmaceuticals, Inc., Buffalo Grove, IL
  • | 3 John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA
Restricted access

Source of Funding: Tolmar Pharmaceuticals, Inc.

Corresponding Author: Stuart N. Atkinson, MB ChB
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 124 124 4
PDF Downloads 132 132 1
EPUB Downloads 0 0 0